Tech Company Financing Transactions

eFFECTOR Therapeutics Funding Round

Pfizer Venture Investments, AbbVie Biotech Ventures and Abingworth joined a $38.6 million Series C funding round for eFFECTOR Therapeutics. The round was announced on 7/25/2017.

Transaction Overview

Company Name
eFFECTOR Therapeutics
Announced On
7/25/2017
Transaction Type
Venture Equity
Amount
$38,600,000
Round
Series C
Investors

Pfizer Venture Investments (Lead Investor) (Elaine Jones)

AbbVie Biotech Ventures

Abingworth (Ken Haas)

Alexandria Venture Investments

Altitude Life Science Ventures (David Maki)

Astellas Venture Capital

BioMed Ventures

Novartis Venture Fund (Markus Goebel)

Sectoral Asset Management (Maha Katabi)

SR One Capital Management (Simeon George)

The Column Group

U.S. Venture Partners (Larry Lasky)

Proceeds Purpose
The Series C proceeds will also enable the company to advance eFT226, an inhibitor of the eukaryotic initiation factor 4A (eIF4A), into the clinic in 2018.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11180 Roselle St.
San Diego, CA 92121
USA
Phone
(858) 925-8215
Website
www.effector.com
Email Address
[email protected]
Overview
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Profile
eFFECTOR Therapeutics LinkedIn Company Profile
Social Media
eFFECTOR Therapeutics Company Twitter Account
Company News
eFFECTOR Therapeutics News
Facebook
eFFECTOR Therapeutics on Facebook
YouTube
eFFECTOR Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Steve Worland
  Steve Worland LinkedIn Profile  Steve Worland Twitter Account  Steve Worland News  Steve Worland on Facebook
Chief Financial Officer
Alana McNulty
  Alana McNulty LinkedIn Profile  Alana McNulty Twitter Account  Alana McNulty News  Alana McNulty on Facebook
VP - R & D
Siegfried Reich
  Siegfried Reich LinkedIn Profile  Siegfried Reich Twitter Account  Siegfried Reich News  Siegfried Reich on Facebook

 

 

Browse more venture capital transactions:

Prev: 7/25/2017: Expert360 venture capital transaction
Next: 7/25/2017: Notable venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to report on every notable VC transaction. All VC database entries on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.